Rafa Laboratories, Ltd.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis, Voyager To Focus First On Hun

As calls increase to move beyond the coronavirus pandemic and return to normal life, sponsors are growing uneasy about the future of the drugs available under emergency use authorizations. EUAs are in

The US Food and Drug Administration’s emergency use authorization for remdesivir includes boilerplate language limiting what Gilead Sciences Inc. can say about the drug – language that was absent fr

An ongoing shortage and increasing demand for a potential treatment for coronavirus could allow Bayer AG to obtain a rarely granted emergency use authorization from the US Food and Drug Administrati